40,000,000 Shares of Common Stock and Warrants to Purchase 40,000,000 Shares of Common Stock Progenity, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • August 23rd, 2021 • Progenity, Inc. • Services-medical laboratories • New York
Contract Type FiledAugust 23rd, 2021 Company Industry JurisdictionProgenity, Inc., a Delaware corporation (the “Company”), proposes to sell to H.C. Wainwright & Co., LLC (the “Underwriter”) an aggregate of (i) 40,000,000 shares (the “Firm Shares”) of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company and (ii) warrants to purchase up to 40,000,000 shares of Common Stock in the form set forth on Exhibit A (the “Firm Warrants”). The Firm Shares consist of 40,000,000 authorized but unissued shares of Common Stock to be issued and sold by the Company. The Company has also granted to the Underwriter an option to purchase up to (i) 6,000,000 additional shares of Common Stock (the “Option Shares”) and/or (ii) warrants to purchase up to 6,000,000 shares of Common Stock in the form set forth on Exhibit A (the “Option Warrants” and together with the Firm Warrants, the “Warrants”) on the terms and for the purposes set forth in Section 3 hereof. The Firm Shares, the Firm Warrants and any Option Shares and Option Warrants purchased pursu
3,500,000 Shares Merit Medical Systems, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 30th, 2018 • Merit Medical Systems Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledJuly 30th, 2018 Company Industry JurisdictionMerit Medical Systems, Inc., a Utah corporation (the “Company”), proposes to sell to Wells Fargo Securities, LLC (“Wells Fargo”) and Piper Jaffray & Co. (“Piper Jaffray” and, together with Wells Fargo, the “Representatives”), and each of the other underwriters named in Schedule A hereto (collectively ,the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof) an aggregate of 3,500,000 shares (the “Firm Shares”) of Common Stock, no par value per share (the “Common Stock”), of the Company. The Company has also granted to the Underwriters an option to purchase up to 525,000 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”